Pitfalls in the design of clinical trials for prevention or treatment of acute graft-versus-host disease

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 1 SUPPL. 2, 2006, Pages 31-36

  Martin, Paul J ^a   Nash, Richard A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Clinical trials; Graft versus host disease; Hematopoietic cell transplantation

Indexed keywords

CYCLOSPORIN; IMMUNOTOXIN; INTERLEUKIN 2 RECEPTOR ALPHA; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOIMMUNITY; CLINICAL RESEARCH; CLINICAL TRIAL; FREQUENCY ANALYSIS; GRAFT SURVIVAL; HUMAN; IMMUNITY; METHODOLOGY; MORBIDITY; MORTALITY; NONMYELOABLATIVE CONDITIONING; PRACTICE GUIDELINE; REVIEW; SOCIOECONOMICS;

EID: 29844442580     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.11.001     Document Type: Article

References (9)

1. V. Ratanatharathorn R.A. Nash D. Przepiorka et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation Blood 92 1998 2303-2314
2. R.A. Nash J.H. Antin C. Karanes Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors Blood 96 2000 2062-2068
3. D.J. Weisdorf D. Hurd S. Carter et al. Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review Biol Blood Marrow Transplant 9 2003 512-518
4. P.J. Martin G. Schoch L. Fisher et al. A retrospective analysis of therapy for acute graft-versus-host disease initial treatment Blood 76 1990 1464-1472
5. P.J. Martin B.J. Nelson F.R. Appelbaum et al. Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation Blood 88 1996 824-830
6. T.A. Gooley P. Rajvanshi H.G. Schoch et al. Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation Hepatology 41 2005 345-352
7. M.M. Horowitz D. Przepiorka P. Bartels et al. Tacrolimus vs cyclosporine immunosuppression: Results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine Biol Blood Marrow Transplant 5 1999 180-186
8. P.J. Martin J. Pei T. Gooley et al. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation Biol Blood Marrow Transplant 10 2004 552-560
9. M.E. Flowers R. Traina B. et al. Storer Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning Bone Marrow Transplant 35 2005 277-282